We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Quest (Moxidectin) equine oral gel seized at East Midlands Airport.
Evaluations made by the Rapid Review Panel (RRP) on submitted products.
Dose of nicotine delivered & uptake and consistency of dose.
Decision on application for authorisation under UK REACH.
How to diagnose and manage infections caused by Shiga toxin-producing Escherichia coli (STEC).
The symptoms, means of transmission, best means of prevention and treatment of hepatitis E.
Product Safety Report for El Paradis Cosmetic Nature Secrete A L'Huile D'Argan presenting a serious chemical risk.
This external quality assessment (EQA) scheme is suitable for laboratories in the water testing and clinical microbiology sectors that monitor the microbial quality of water used rinse endoscopes.
This external quality assessment (EQA) scheme is suitable for laboratories located on production sites where it may be inadvisable to introduce pathogens.
Advice on ingredients in nicotine-containing liquids in electronic cigarettes and refill containers.
This external quality assessment (EQA) scheme is suitable for laboratories located on production sites where the introduction of pathogens may be inadvisable.
A 10-year plan to cut crime and save lives by reducing the supply and demand for drugs and delivering a high-quality treatment and recovery system.
PHE has undertaken assessments of inactivation methods against SARS-CoV-2 with further evaluations ongoing.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine etrasimod (Velsipity) to treat people with moderately to severely active ulcerative colitis.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).